CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹32 Cr | ₹32 Cr | ₹54 Cr | ₹77 Cr | ₹55 Cr |
What is the latest Total Non-Current Liabilities ratio of CONCORD BIOTECH ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹32 Cr |
Mar2023 | ₹32 Cr |
Mar2022 | ₹54 Cr |
Mar2021 | ₹77 Cr |
Mar2020 | ₹55 Cr |
How is Total Non-Current Liabilities of CONCORD BIOTECH Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹32 Cr | -0.71 | |
Mar2023 | ₹32 Cr | -40.93 | |
Mar2022 | ₹54 Cr | -29.74 | |
Mar2021 | ₹77 Cr | 40.32 | |
Mar2020 | ₹55 Cr | - |
Compare Total Non-Current Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹19,192.5 Cr | 2.4% | -13.1% | 6.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 2.4% |
-13.1% |
6.1% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses